IBB ETF holdings (NASDAQ) - Page 8 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

JANX Janux Therapeutics, Inc. 5.45 M 392.35 K 0.07%

PHVS Pharvaris NV 5.42 M 191.96 K 0.07%

MNKD MannKind Corp. 5.39 M 2.20 M 0.07%

ORIC ORIC Pharmaceuticals, Inc. 5.38 M 424.42 K 0.07%

CSTL Castle Biosciences, Inc. 5.30 M 215.69 K 0.07%

ANNX Annexon, Inc. 5.28 M 952.88 K 0.06%

URGN UroGen Pharma Ltd. 5.14 M 286.04 K 0.06%

KURA Kura Oncology, Inc. 5.11 M 628.45 K 0.06%

INBX Inhibrx Biosciences, Inc. 5.10 M 75.83 K 0.06%

STVN Stevanato Group SpA 5.09 M 370.39 K 0.06%

ABUS Arbutus Biopharma Corp. 5.04 M 1.12 M 0.06%

SEPN Septerna, Inc. 4.83 M 200.84 K 0.06%

ANRO Alto Neuroscience, Inc. 4.78 M 212.68 K 0.06%

BCAX Bicara Therapeutics, Inc. 4.71 M 236.86 K 0.06%

GHRS GH Research plc 4.70 M 334.16 K 0.06%

AVBP ArriVent Biopharma, Inc. 4.64 M 201.24 K 0.06%

CTMX CytomX Therapeutics, Inc. 4.64 M 987.40 K 0.06%

CGEM Cullinan Therapeutics, Inc. 4.60 M 323.43 K 0.06%

REPL Replimune Group, Inc. 4.37 M 570.93 K 0.05%

PGEN Precigen, Inc. 4.28 M 1.10 M 0.05%

1
...
6
7
8
9
10
11
12
13

Notizie

UBS elenca 5 motivi chiave per cui le azioni biotech a media capitalizzazione dovrebbero performare bene nel 2026